These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1057 related items for PubMed ID: 19622618

  • 1. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
    Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4757-67. PubMed ID: 19864450
    [Abstract] [Full Text] [Related]

  • 3. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [Abstract] [Full Text] [Related]

  • 4. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K.
    J Natl Cancer Inst; 2012 May 02; 104(9):700-8. PubMed ID: 22517990
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul 02; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 6. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
    Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K.
    J Nucl Med; 2007 Oct 02; 48(10):1599-606. PubMed ID: 17873132
    [Abstract] [Full Text] [Related]

  • 7. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.
    J Nucl Med; 2015 Jun 02; 56(6):839-46. PubMed ID: 25883126
    [Abstract] [Full Text] [Related]

  • 8. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K.
    Eur J Endocrinol; 2007 Apr 02; 156(4):483-7. PubMed ID: 17389464
    [Abstract] [Full Text] [Related]

  • 9. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.
    Derlin T, Busch JD, Wisotzki C, Schoennagel BP, Bannas P, Papp L, Klutmann S, Habermann CR.
    Clin Nucl Med; 2013 Jan 02; 38(1):e1-6. PubMed ID: 22996238
    [Abstract] [Full Text] [Related]

  • 10. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma.
    Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, Pacak K.
    J Clin Endocrinol Metab; 2003 Sep 02; 88(9):4083-7. PubMed ID: 12970267
    [Abstract] [Full Text] [Related]

  • 11. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.
    Anticancer Res; 2014 Feb 02; 34(2):791-5. PubMed ID: 24511014
    [Abstract] [Full Text] [Related]

  • 12. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
    Marzola MC, Chondrogiannis S, Grassetto G, Rampin L, Maffione AM, Ferretti A, Opocher G, Schiavi F, Colletti PM, Rubello D.
    Clin Nucl Med; 2014 Jan 02; 39(1):e53-8. PubMed ID: 23856824
    [Abstract] [Full Text] [Related]

  • 13. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K.
    J Clin Oncol; 2007 Jun 01; 25(16):2262-9. PubMed ID: 17538171
    [Abstract] [Full Text] [Related]

  • 14. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC, Benz MR, Wild D, Mix M, Dumont RA, Campbell D, Seufert J, Wiech T, Rössler J, Weber WA, Neumann HP.
    J Nucl Med; 2012 Sep 01; 53(9):1352-8. PubMed ID: 22836345
    [Abstract] [Full Text] [Related]

  • 15. 68Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET/CT and 123I-MIBG SPECT/CT.
    Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Url C, Riechelmann H, Sprinzl GM, Thomé C, Treglia G, Kjaer A, Fraedrich G, Virgolini IJ.
    Nucl Med Biol; 2019 Apr 01; 71():47-53. PubMed ID: 31152973
    [Abstract] [Full Text] [Related]

  • 16. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J, Pacak K.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):311-23. PubMed ID: 18310297
    [Abstract] [Full Text] [Related]

  • 17. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
    Grassi I, Nanni C, Vicennati V, Castellucci P, Allegri V, Montini GC, Pagotto U, di Dalmazi G, Pasquali R, Fanti S.
    Clin Nucl Med; 2011 Feb 01; 36(2):124-6. PubMed ID: 21220975
    [Abstract] [Full Text] [Related]

  • 18. Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.
    Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP.
    Radiology; 2002 Feb 01; 222(2):507-12. PubMed ID: 11818620
    [Abstract] [Full Text] [Related]

  • 19. Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.
    Kroiss AS, Uprimny C, Shulkin BL, Frech A, Tilg H, Gasser RW, Sprinzl GM, Gruber L, Thomé C, Plangger C, Url C, Fraedrich G, Virgolini IJ.
    Ann Nucl Med; 2017 Jun 01; 31(5):357-365. PubMed ID: 28349331
    [Abstract] [Full Text] [Related]

  • 20. Imaging of pheochromocytoma and paraganglioma.
    Brink I, Hoegerle S, Klisch J, Bley TA.
    Fam Cancer; 2005 Jun 01; 4(1):61-8. PubMed ID: 15883712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.